Independent research on the U.S. markets, Baptista Research

Baptista Research

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. 

We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>Flowserve has entered 2025 with renewed operational momentum, expanding margins, rising free cash flow, and a clearer strategic focus shaped by the Flowserve Business System and its 80/20 simplification framework.</li><li>Recent quarters have highlighted accelerating aftermarket growth, record nuclear bookings, and a balance sheet that now offers greater flexibility following disciplined capital allocation and the divestiture of legacy asbestos liabilities.</li><li>Against this backdrop, investor attention has increasingly turned toward how Flowserve could further deepen its exposure to high-barrier, specification-driven markets such as nuclear, power, and severe-service industrial applications.</li></ul>

Flowserve has entered 2025 with renewed operational momentum, expanding margins, rising free cash flow, and a clearer strategic focus shaped by the Flowserve Business System and its 80/20 simplification framework.Recent quarters have highlighted accelerating aftermarket growth, record nuclear bookings, and a balance sheet that now offers greater flexibility following disciplined capital allocation and the divestiture of legacy asbestos liabilities.Against this backdrop, investor attention has increasingly turned toward how Flowserve could further deepen its exposure to high-barrier, specification-driven markets such as nuclear, power, and severe-service industrial applications.

Flowserve's Trillium Angle: Margin Expansion, Nuclear Exposure, And Execution Risk!

Flowserve Corp

Flowserve's Trillium Angle: Margin Expansion, Nuclear Exposure, And Execution Risk!